Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/26 16:09 | 6/12/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Snyder Mark Howard | CA | O | SVP,GC | 1 | M.d | 0 | 0.00 | 0 | 5 | 11 | 50 | D | ||||||||||||||
6/3/26 20:06 | 6/1/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 8 | M.dm | 11,842 | 39.47 | 0 | 300 | 64 | 768 | D | ||||||||||||||
6/3/26 20:06 | 6/1/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 8 | S.dm | -11,842 | 39.47 | 0 | -300 | 768 | D | |||||||||||||||
6/2/26 17:20 | 6/1/26 | HALO | Health | BioPrd | Biological Products, (No Diag | Connaughton Bernadette | CA | D | 2 | S | -211 | 64.84 | 0 | -3 | 44 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |